The role of [18F]FDG PET/CT for gastric cancer management

被引:3
|
作者
Salmanoglu, Ebru [1 ]
机构
[1] Kahramanmaras Sutcu Imam Univ, Fac Med, Dept Nucl Med, Avsar Kampus, TR-46040 Kahramanmaras, Turkey
关键词
gastric cancer; PET/CT; F-18]FDG; POSITRON-EMISSION-TOMOGRAPHY; F-18-FDG PET/CT; FDG-PET; COMPUTED-TOMOGRAPHY; PROGNOSTIC VALUE; PERFORMANCE; PARAMETERS; SURVEILLANCE; SURVIVAL;
D O I
10.5603/NMR.2021.0021
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Gastric cancer (GC) is a common cause of cancer-related deaths in the world. In addition to the patient's clinical history and clinical examination, nuclear medicine tools are required for diagnosis. [F-18]FDG PET/CT has been commonly used for cancer patients for staging, restaging, evaluation of treatment response. This study aimed to review the current literature on the role of [F-18]FDG PET/CT for GC management.
引用
收藏
页码:99 / 103
页数:5
相关论文
共 50 条
  • [41] Role of [18F]FDG-PET/CT in the detection of occult recurrent medullary thyroid cancer
    Skoura, Evangelia
    Rondogianni, Phivi
    Alevizaki, Maria
    Tzanela, Marinella
    Tsagarakis, Stylianos
    Piaditis, George
    Tolis, George
    Datseris, Ioannis E.
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2010, 31 (06) : 567 - 575
  • [42] The role of [18F]FDG-PET/CT in the detection of occult recurrent medullary thyroid cancer
    Skoura, E.
    Rondogianni, P.
    Exarhos, D.
    Drougas, D.
    Skilakaki, M.
    Datseris, I. E.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S99 - S100
  • [43] Fluoromethylcholine (18F)PET/CT for staging hepatocellular carcinoma: prospective comparison with FDG (18F) PET/CT.
    Balogova, S.
    Huchet, V.
    Nataf, V.
    Kerrou, K.
    Fartoux, L.
    Bumsel, F.
    Ancel, D.
    Montravers, F.
    Grange, J. D.
    Rosmorduc, O.
    Talbot, J. N.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S177 - S177
  • [44] PET/CT in patients with hepatocellular carcinoma using [18F] fluorocholine:: preliminary comparison with [18F]FDG PET/CT
    Talbot, Jean-Noël
    Gutman, Fabrice
    Fartoux, Laetitia
    Grange, Jean-Didier
    Ganne, Nathalie
    Kerrou, Khaldoun
    Grahek, Dany
    Montravers, Francoise
    Poupon, Raoul
    Rosmorduc, Olivier
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (11) : 1285 - 1289
  • [45] The Incremental Value of 18F FDG Labelled Leukocytes PET CT Over 18F FDG PET CT Scan in the Detection of Occult Infection
    Manda, D.
    Sen, I.
    Thakral, P.
    Malik, D.
    Das, S. S.
    Cb, V.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S88 - S88
  • [46] Role of 18F FDG PET CT in restaging of oesophageal cancer after curative surgical resection
    Shantanu, Pande
    Sayak, Choudhury
    Ameya, Puranik
    Shah, Sneha
    Agrawal, Archi
    Purandare, Nilendu
    Rangarajan, Venkatesh
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [47] PET/CT in patients with hepatocellular carcinoma using [18F]fluorocholine: preliminary comparison with [18F]FDG PET/CT
    Jean-Noël Talbot
    Fabrice Gutman
    Laetitia Fartoux
    Jean-Didier Grange
    Nathalie Ganne
    Khaldoun Kerrou
    Dany Grahek
    Françoise Montravers
    Raoul Poupon
    Olivier Rosmorduc
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2006, 33 : 1285 - 1289
  • [48] [18F]-Sodium Fluoride PET and [18F]-FDG PET/CT in prediction of aortic stenosis progression
    Ryzhkova, D. V.
    Kukushkina, S.
    Murtazalieva, P.
    Irtyuga, O.
    Malev, E.
    Moiseeva, O.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S256 - S257
  • [49] Comparison of Diagnostic Sensitivity Between [18F]Florastamin and [18F]FDG PET/CT in the Patients with Prostate Cancer
    Lee, Inki
    Lim, Ilhan
    Byun, Byung Hyun
    Kim, Byung Il
    Choi, Chang Woon
    Lee, Kyo Chul
    Kang, Joo Hyun
    Chi, Dae Yoon
    Park, Jongwook
    Song, Kanghyon
    Lim, Sang Moo
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2022, 63
  • [50] WHAT IS THE ADDITIONAL ROLE OF 18F FDG-PET/CT ON THERAPY MANAGEMENT DURING FOLLOW UP IN BREAST CANCER?
    Blumstein, N. M.
    Jager, G.
    Reske, S. N.
    Aebersold, D. M.
    Kurzeder, M.
    Blumstein, C. G.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 (12) : 735 - 736